Intratekalt morfin möjlig behandling vid svår restless legs

Lakartidningen

Volumn 104, Issue 32-33, 2007, Pages 2250-2252

  Lindvall, Peter K J ^a   Ruuth, Krister ^b   Jakobsson, Bengt ^b   Nilsson, Stefan K ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^b Anestesikliniken   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

MORPHINE; NARCOTIC ANALGESIC AGENT;

ARTICLE; FOLLOW UP; HUMAN; INFUSION PUMP; INTRASPINAL DRUG ADMINISTRATION; RESTLESS LEGS SYNDROME; TREATMENT OUTCOME;

ANALGESICS, OPIOID; FOLLOW-UP STUDIES; HUMANS; INFUSION PUMPS, IMPLANTABLE; INJECTIONS, SPINAL; MORPHINE; RESTLESS LEGS SYNDROME; TREATMENT OUTCOME;

EID: 34548360503     PISSN: 00237205     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Ekbom K. Restless legs. Acta Med Scand. Suppl. 1945;158(1-123).
2. Ekbom K, Leissner L, Olsson JE, Widner H. Restless legs - vanligt sjukdomstillstånd som ofta missas. Möjlighet till framgångsrik behandling finns idag. Läkartidningen. 2006;103(4):207-11.
3. Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisi J. Restless legs syndrome: Diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med. 2003;4(2):101-19.
4. Allen RP, Earley CJ. Restless legs syndrome: A review of clinical and pathophysiologic features. J Clin Neurophysiol. 2001;18(2):128-47.
5. Earley CJ. Clinical practice. Restless legs syndrome. N Engl J Med. 2003;348(21):2103-9.
6. Levchenko A, Provost S, Montplaisir JY, Xiong L, St-Onge J, Thibodeau P, et al. A novel autosomal dominant restless legs syndrome locus maps to chromosome 20p13. Neurology. 2006;67(5):900-1.
7. O'Keeffe ST, Noel J, Lavan JN. Restless legs syndrome in the eld erly. Postgrad Med J. 1993;69(815):701-3.
8. Clemens S, Rye D, Hochman S. Restless legs syndrome: Revisiting the dopamine hypothesis from the spinal cord perspective. Neurology. 2006;67(1):125-30.
9. Gerber HR. Intrathecal morphine for chronic benign pain. Best Pract Res Clin Anaesthesiol. 2003;17(3):429-42.
10. Follett KA, Naumann CP. A prospective study of catheter-related complications of intrathecal drug delivery systems. J Pain Symptom Manage. 2000;19(3):209-15.
11. Jakobsson B, Ruuth K. Successful treatment of restless legs syndrome with an implanted pump for intrathecal drug delivery. Acta Anaesthesiol Scand. 2002;46(1):114-7.
12. Plummer JL, Cmielewski PL, Gourlay GK, Owen H, Cousins MJ. Antinociceptive and motor effects of intrathecal morphine combined with intrathecal clonidine, noradrenaline, carbachol or midazolam in rats. Pain. 1992;49(1):145-52.
13. Paice JA, Penn RD, Shott S. Intraspinal morphine for chronic pain: A retrospective, multicenter study. J Pain Symptom Manage. 1996;11(2):71-80.
14. Moulin DE, Inturrisi CE, Foley KM. Cerebrospinal fluid pharmacokinetics of intrathecal morphine sulfate and D-Ala2-D-Leu5-enkephalin. Ann Neurol. 1986;20(2):218-22.
15. Paulus W, Schomburg ED. Dopamine and the spinal cord in restless legs syndrome: Does spinal cord physiology reveal a basis for augmentation? Sleep Med Rev. 2006;10(3):185-96.
16. Scherens A, Kagel T, Zenz M, Maier C. Long-term respiratory depression induced by intrathecal morphine treatment for chronic neuropathic pain. Anesthesiology. 2006;105(2):431-3.